Compounds > amphetamine

amphetamine and cyc 202

amphetamine has been researched along with cyc 202 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Bubula, N; Forneris, J; Li, D; Neugebauer, NM; Rodvelt, KR; Singer, BF; Vezina, P1
Forneris, J; Singer, BF; Vezina, P1

Other Studies

3 other study(ies) available for amphetamine and cyc 202

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Locomotor conditioning by amphetamine requires cyclin-dependent kinase 5 signaling in the nucleus accumbens.
    Neuropharmacology, 2014, Volume: 85

    Topics: Amphetamine; Animals; Central Nervous System Stimulants; Conditioning, Psychological; Cyclin-Dependent Kinase 5; Guanine Nucleotide Exchange Factors; Male; Motor Activity; Mutation; Nucleus Accumbens; Phosphorylation; Protein Kinase Inhibitors; Purines; Rats, Sprague-Dawley; Roscovitine; Signal Transduction

2014
Inhibiting cyclin-dependent kinase 5 in the nucleus accumbens enhances the expression of amphetamine-induced locomotor conditioning.
    Behavioural brain research, 2014, Dec-15, Volume: 275

    Topics: Amphetamine; Animals; Central Nervous System Stimulants; Cyclin-Dependent Kinase 5; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Locomotion; Male; Microinjections; Nucleus Accumbens; Purines; Rats; Rats, Sprague-Dawley; Roscovitine; Time Factors

2014